GeneDx Holdings Corp. (WGS) Insider Trading

GeneDx Holdings Corp. (WGS) has 14 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 18, 2026.

Filings
14
Purchases
0
$0
Sales
0
$0
Insiders
10

Most active WGS insiders

Stueland Katherine
CHIEF EXECUTIVE OFFICER
0 bought · 0 sold · Sept. 18, 2026
$1.3M
Feeley Kevin
CHIEF FINANCIAL OFFICER
0 bought · 0 sold · Sept. 18, 2026
$503K
GARDNER MARK A
President
0 bought · 0 sold · July 1, 2026
$0
Leproust Emily M.
Director
0 bought · 0 sold · June 23, 2026
$0
Casdin Eli
Director
0 bought · 0 sold · June 23, 2026
$0
PFENNIGER RICHARD C JR
Director
0 bought · 0 sold · June 23, 2026
$0
RUCH JOSHUA
Director
0 bought · 0 sold · June 23, 2026
$0
Ryan Jason
Director
0 bought · 0 sold · June 23, 2026
$0

Latest WGS Form 4 filings

Date Insider Value Shares Stake Pre-planned Links
Sept. 18, 2026 filed Sept. 16, 2026 Stueland Katherine CHIEF EXECUTIVE OFFICER +8,249 +28% No
Sept. 18, 2026 filed Sept. 17, 2026 Fuchs Thomas Director $0 2,292 +100% No
Sept. 18, 2026 filed Sept. 16, 2026 Feeley Kevin CHIEF FINANCIAL OFFICER +3,469 +32% No
Sept. 11, 2026 filed Sept. 9, 2026 Stueland Katherine CHIEF EXECUTIVE OFFICER +2,855 +77% No
Sept. 11, 2026 filed Sept. 9, 2026 Feeley Kevin CHIEF FINANCIAL OFFICER +1,177 +92% No

Showing the 5 most recent of 14 filings in the last 90 days.

About this data

Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.

Get alerted when WGS insiders trade

Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.

Start free